Literature DB >> 7129487

Characterization of a cell line (SW756) derived from a human squamous carcinoma of the uterine cervix.

R S Freedman, J M Bowen, A Leibovitz, S Pathak, M J Siciliano, H S Gallager, B C Giovanella.   

Abstract

An established cell line, SW756, derived from a primary squamous carcinoma of the uterine cervix is described by its morphology, ultrastructure, karyotype, genetic signature analysis, HLA typing, and tumorigenesis in the nude mouse. Cultured cells obtained from the SW756 derived nude mouse tumor also were studied for chromosome and isozyme markers. The original tumor was poorly differentiated carcinoma with minimal keratinization and is compared with that occurring in the nude mouse after the cultured cells were inoculated. The nude mouse tumor showed similar histological features, but better differentiation than the original tumor. Karyotype analysis of SW756 demonstrated a hyperdiploid stem line number and several marker chromosomes (MI-M6). No HeLa marker chromosomes were identified. The isozyme pattern for SW756 reported by others has been confirmed. The unique chromosome and isozyme features have been identified repeatedly in the cultured cells and, most importantly, in the post nude mouse culture. We recommend SW756 as a defined human tumorigenic cell line derived from a primary squamous carcinoma of the uterine cervix.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7129487     DOI: 10.1007/bf02796428

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  24 in total

1.  Human tumours in mice confirmed by chromosomal analysis.

Authors:  M R Bordelon; E Stubblefield
Journal:  Nature       Date:  1974-11-22       Impact factor: 49.962

2.  Development of invasive tumors in the "nude" mouse after injection of cultured human melanoma cells.

Authors:  B C Giovanella; S O Yim; J S Stehlin; L J Williams
Journal:  J Natl Cancer Inst       Date:  1972-05       Impact factor: 13.506

3.  Quinacrine fluorescent karyotypes of human diploid and heteroploid cell lines.

Authors:  O J Miller; D A Miller; P W Allderdice; V G Dev; M S Grewal
Journal:  Cytogenetics       Date:  1971

4.  Chromosome analysis and alkaline phosphatase of C41, a cell line of human cervical origin distinct from HeLa.

Authors:  F Herz; O J Miller; D A Miller; N Auersperg; L G Koss
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

5.  Inter- and intraspecies contamination of human breast tumor cell lines HBC and BrCa5 and other cell cultures.

Authors:  W A Nelson-Rees; R R Flandermeyer
Journal:  Science       Date:  1977-03-25       Impact factor: 47.728

6.  Enzyme polymorphisms as genetic signatures in human cell cultures.

Authors:  S U O'Brien; G Kleiner; R Olson; J E Shannon
Journal:  Science       Date:  1977-03-25       Impact factor: 47.728

7.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Authors:  J Fogh; W C Wright; J D Loveless
Journal:  J Natl Cancer Inst       Date:  1977-02       Impact factor: 13.506

8.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

9.  Mutually exclusive genetic signatures of human breast tumor cell lines with a common chromosomal marker.

Authors:  M J Siciliano; P E Barker; R Cailleau
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

10.  HLA-A, B, C and DR alloantigen expression on forty-six cultured human tumor cell lines.

Authors:  M S Pollack; S D Heagney; P O Livingston; J Fogh
Journal:  J Natl Cancer Inst       Date:  1981-06       Impact factor: 13.506

View more
  12 in total

1.  Human papillomavirus type 18 DNA is integrated at a single chromosome site in cervical carcinoma cell line SW756.

Authors:  N C Popescu; S C Amsbaugh; J A DiPaolo
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

2.  Oncostatin M treatment increases the responsiveness toward cisplatin-based chemoradiotherapy in cervical cancer cells in a STAT3-dependent manner.

Authors:  Russalina Stroeder; Barbara Walch-Rückheim; Jil Fischbach; Ingolf Juhasz-Böss; Christian Rübe; Erich-Franz Solomayer; Sigrun Smola
Journal:  Oncol Lett       Date:  2018-06-18       Impact factor: 2.967

3.  Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells.

Authors:  M von Knebel Doeberitz; T Bauknecht; D Bartsch; H zur Hausen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

4.  Virus-augmented delayed hypersensitivity skin tests in gynecological malignancies.

Authors:  R S Freedman; J M Bowen; E N Atkinson; W Scott; S Wagner
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

5.  Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines.

Authors:  C D Woodworth; S Simpson
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

6.  Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.

Authors:  M von Knebel Doeberitz; C Rittmüller; F Aengeneyndt; P Jansen-Dürr; D Spitkovsky
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

7.  Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes.

Authors:  A Schneider-Gädicke; E Schwarz
Journal:  EMBO J       Date:  1986-09       Impact factor: 11.598

8.  Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer.

Authors:  Edgar Grinstein; Peter Wernet; Peter J F Snijders; Frank Rösl; Inge Weinert; Wentao Jia; Regine Kraft; Christiane Schewe; Michael Schwabe; Steffen Hauptmann; Manfred Dietel; Chris J L M Meijer; Hans-Dieter Royer
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

9.  XH1--a new cervical carcinoma cell line and xenograft model of tumour invasion, 'metastasis' and regression.

Authors:  X Han; R Lyle; D L Eustace; R J Jewers; J M Parrington; A Das; T Chana; B Dagg; S Money; T D Bates
Journal:  Br J Cancer       Date:  1991-10       Impact factor: 7.640

10.  5-aza-2'-deoxycytidine (DAC) treatment downregulates the HPV E6 and E7 oncogene expression and blocks neoplastic growth of HPV-associated cancer cells.

Authors:  Maximilian Stich; Lennard Ganss; Jens Puschhof; Elena-Sophie Prigge; Miriam Reuschenbach; Ana Guiterrez; Svetlana Vinokurova; Magnus von Knebel Doeberitz
Journal:  Oncotarget       Date:  2016-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.